Related Experiment Video
Updated: Jul 4, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
Published on: January 10, 2025
Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency
Flavia Guillem1, Sarah Lawson, Caroline Kannengiesser
1Assistance Publique des Hôpitaux de Paris (APHP), Laboratoire de Génétique et Biochimie Hormonale, Hôpital Bichat, Paris, France.
Abstract:
Genetic causes of hypochromic microcytic anemia include thalassemias and some rare inherited diseases such as DMT1 deficiency. Here, we show that iron deficiency anemia with poor intestinal absorption and defective iron utilization of IV iron is caused by inherited mutations in TMPRSS6, a liver-expressed gene that encodes a membrane-bound serine protease of previously unknown role that was recently reported to be a regulator of hepcidin expression.
Insights
Inherited mutations in TMPRSS6 cause iron deficiency anemia due to poor iron absorption and utilization. This finding reveals a new genetic cause for this common blood disorder.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Hypochromic microcytic anemia has known genetic causes like thalassemias and DMT1 deficiency.
- TMPRSS6, a liver-expressed serine protease, was recently identified as a regulator of hepcidin expression.
Observation:
- This study investigated a form of iron deficiency anemia characterized by poor intestinal iron absorption and defective utilization of intravenous iron.
- The researchers identified inherited mutations in the TMPRSS6 gene as the underlying cause of this specific anemia phenotype.
Findings:
- Inherited mutations in TMPRSS6 lead to iron deficiency anemia with impaired iron absorption and utilization.
- TMPRSS6 encodes a membrane-bound serine protease crucial for iron homeostasis.
Implications:
- This research identifies TMPRSS6 mutations as a novel genetic cause of iron deficiency anemia.
- Understanding TMPRSS6's role offers new insights into iron metabolism regulation and potential therapeutic targets.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...